Cost-benefit impact of free asthma medication provision for the pediatric population

Asthma is a common chronic disease in childhood, resulting in high costs for health care systems and society. As of June 2011, the Brazilian Unified Health System (SUS) provides free asthma medications for the population. This study evaluated the impact of this program on asthma admissions in the po...

Full description

Saved in:
Bibliographic Details
Published inRespiratory medicine Vol. 164; p. 105915
Main Authors Koltermann, Vanessa, Friedrich, Frederico Orlando, Fensterseifer, Ana Carolina, Ongaratto, Renata, Pinto, Leonardo Araújo
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.04.2020
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Asthma is a common chronic disease in childhood, resulting in high costs for health care systems and society. As of June 2011, the Brazilian Unified Health System (SUS) provides free asthma medications for the population. This study evaluated the impact of this program on asthma admissions in the population aged 1–19 years. In addition, a cost-benefit analysis compared data before and after the introduction of the program. This descriptive study was based on information from SUS Information Technology Department (DATASUS). Admission rates and costs of patients aged 1–19 years with diagnosed asthma were compared before (2008–2010) and after (2012–2017) the provision of free inhaled corticosteroid. The asthma admission rate reduced by 28.4% when comparing the two periods (OR 0.71; 95% CI 0.64–0.79). Children aged 1–4 years had a 27.3% reduction in asthma admissions (OR 0.72; 95% CI 0.63–0.82), while those aged 15–19 years had a 39.65% decrease (OR 0.59; 95% CI 0.37–0.95). Asthma admission costs decreased when comparing the two periods (OR 0.68; 95% CI 0.62–0.74). After the introduction of the program, mean cost savings reached US $27,865,905.08 in children aged 1–4 years and US $21,350,660.63 in those aged 5–19 years. The economic burden of pediatric asthma on Brazil's public health care system is significant. From 2012 to 2015, free provision of inhaled corticosteroid was cost-effective in all age groups. In 2017, no cost-benefit effect was observed in this population, but asthma admission rate decreased. •Pediatric asthma imposes a significant economic burden on health care systems.•Brazilin public health system provides free asthma medications for the population.•The asthma admission rate and costs decreased after the introduction of the program.•Free provision of inhaled corticosteroid was cost-effective in all age group.
AbstractList BACKGROUNDAsthma is a common chronic disease in childhood, resulting in high costs for health care systems and society. As of June 2011, the Brazilian Unified Health System (SUS) provides free asthma medications for the population. This study evaluated the impact of this program on asthma admissions in the population aged 1-19 years. In addition, a cost-benefit analysis compared data before and after the introduction of the program. METHODSThis descriptive study was based on information from SUS Information Technology Department (DATASUS). Admission rates and costs of patients aged 1-19 years with diagnosed asthma were compared before (2008-2010) and after (2012-2017) the provision of free inhaled corticosteroid. RESULTSThe asthma admission rate reduced by 28.4% when comparing the two periods (OR 0.71; 95% CI 0.64-0.79). Children aged 1-4 years had a 27.3% reduction in asthma admissions (OR 0.72; 95% CI 0.63-0.82), while those aged 15-19 years had a 39.65% decrease (OR 0.59; 95% CI 0.37-0.95). Asthma admission costs decreased when comparing the two periods (OR 0.68; 95% CI 0.62-0.74). After the introduction of the program, mean cost savings reached US $27,865,905.08 in children aged 1-4 years and US $21,350,660.63 in those aged 5-19 years. CONCLUSIONThe economic burden of pediatric asthma on Brazil's public health care system is significant. From 2012 to 2015, free provision of inhaled corticosteroid was cost-effective in all age groups. In 2017, no cost-benefit effect was observed in this population, but asthma admission rate decreased.
Asthma is a common chronic disease in childhood, resulting in high costs for health care systems and society. As of June 2011, the Brazilian Unified Health System (SUS) provides free asthma medications for the population. This study evaluated the impact of this program on asthma admissions in the population aged 1-19 years. In addition, a cost-benefit analysis compared data before and after the introduction of the program. This descriptive study was based on information from SUS Information Technology Department (DATASUS). Admission rates and costs of patients aged 1-19 years with diagnosed asthma were compared before (2008-2010) and after (2012-2017) the provision of free inhaled corticosteroid. The asthma admission rate reduced by 28.4% when comparing the two periods (OR 0.71; 95% CI 0.64-0.79). Children aged 1-4 years had a 27.3% reduction in asthma admissions (OR 0.72; 95% CI 0.63-0.82), while those aged 15-19 years had a 39.65% decrease (OR 0.59; 95% CI 0.37-0.95). Asthma admission costs decreased when comparing the two periods (OR 0.68; 95% CI 0.62-0.74). After the introduction of the program, mean cost savings reached US $27,865,905.08 in children aged 1-4 years and US $21,350,660.63 in those aged 5-19 years. The economic burden of pediatric asthma on Brazil's public health care system is significant. From 2012 to 2015, free provision of inhaled corticosteroid was cost-effective in all age groups. In 2017, no cost-benefit effect was observed in this population, but asthma admission rate decreased.
Asthma is a common chronic disease in childhood, resulting in high costs for health care systems and society. As of June 2011, the Brazilian Unified Health System (SUS) provides free asthma medications for the population. This study evaluated the impact of this program on asthma admissions in the population aged 1–19 years. In addition, a cost-benefit analysis compared data before and after the introduction of the program. This descriptive study was based on information from SUS Information Technology Department (DATASUS). Admission rates and costs of patients aged 1–19 years with diagnosed asthma were compared before (2008–2010) and after (2012–2017) the provision of free inhaled corticosteroid. The asthma admission rate reduced by 28.4% when comparing the two periods (OR 0.71; 95% CI 0.64–0.79). Children aged 1–4 years had a 27.3% reduction in asthma admissions (OR 0.72; 95% CI 0.63–0.82), while those aged 15–19 years had a 39.65% decrease (OR 0.59; 95% CI 0.37–0.95). Asthma admission costs decreased when comparing the two periods (OR 0.68; 95% CI 0.62–0.74). After the introduction of the program, mean cost savings reached US $27,865,905.08 in children aged 1–4 years and US $21,350,660.63 in those aged 5–19 years. The economic burden of pediatric asthma on Brazil's public health care system is significant. From 2012 to 2015, free provision of inhaled corticosteroid was cost-effective in all age groups. In 2017, no cost-benefit effect was observed in this population, but asthma admission rate decreased. •Pediatric asthma imposes a significant economic burden on health care systems.•Brazilin public health system provides free asthma medications for the population.•The asthma admission rate and costs decreased after the introduction of the program.•Free provision of inhaled corticosteroid was cost-effective in all age group.
ArticleNumber 105915
Author Pinto, Leonardo Araújo
Ongaratto, Renata
Koltermann, Vanessa
Friedrich, Frederico Orlando
Fensterseifer, Ana Carolina
Author_xml – sequence: 1
  givenname: Vanessa
  surname: Koltermann
  fullname: Koltermann, Vanessa
  email: vanessa.koltermann@gmail.com, vkoltermannpucrs@yahoo.com.br
  organization: Department of Pediatrics, Infant Center, Pontificia Universidade Católica do Rio Grande do Sul, Ipiranga Avenue 6690, Building 60, 2 nd floor, 90610-000, Porto Alegre, RS, Brazil
– sequence: 2
  givenname: Frederico Orlando
  surname: Friedrich
  fullname: Friedrich, Frederico Orlando
  email: fredericofriedrich@gmail.com
  organization: Department of Pediatrics, Infant Center, Pontificia Universidade Católica do Rio Grande do Sul, Ipiranga Avenue 6690, Building 60, 2 nd floor, 90610-000, Porto Alegre, RS, Brazil
– sequence: 3
  givenname: Ana Carolina
  surname: Fensterseifer
  fullname: Fensterseifer, Ana Carolina
  email: anacarolinafens@gmail.com
  organization: Medical School, Pontificia Universidade Católica do Rio Grande do Sul, Ipiranga Avenue 6690, Building 60, 90610-000, Porto Alegre, RS, Brazil
– sequence: 4
  givenname: Renata
  surname: Ongaratto
  fullname: Ongaratto, Renata
  email: re_ongaratto@hotmail.com
  organization: Department of Pediatrics, Infant Center, Pontificia Universidade Católica do Rio Grande do Sul, Ipiranga Avenue 6690, Building 60, 2 nd floor, 90610-000, Porto Alegre, RS, Brazil
– sequence: 5
  givenname: Leonardo Araújo
  surname: Pinto
  fullname: Pinto, Leonardo Araújo
  email: leonardo.pinto@pucrs.br
  organization: Department of Pediatrics, Infant Center, Pontificia Universidade Católica do Rio Grande do Sul, Ipiranga Avenue 6690, Building 60, 2 nd floor, 90610-000, Porto Alegre, RS, Brazil
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32217290$$D View this record in MEDLINE/PubMed
BookMark eNp9kEtLJDEQgIMoOrr7B_awBLx46TGVTj8CXpbBVUHw4p5DJqlghulOm6SF_femd_SyB0-pVH314Dsnx2MYkZAfwNbAoL3ereOAds0ZXxKNhOaIrKCpeVWzVhyTFZONqFoAOCPnKe0YY1IIdkrOas6h45KtyPMmpFxtcUTnM_XDpE2mwVEXEalO-WXQtCzxRmcfRjrF8ObTErkQaX5BOpWiztEbOoVp3v_DvpETp_cJv3-8F-TP79vnzX31-HT3sPn1WBnB-1wBq51kVhrogTcSXUm0dbvtrLZWWiG44Nh3NbOdtdg3ALIzAM7K8m-NrC_I1WFuOet1xpTV4JPB_V6PGOakeN0LDowLKOjlf-guzHEs16mypWkll7IpFD9QJoaUIjo1RT_o-FcBU4tztVOLc7U4Vwfnpennx-h5u9Q-Wz4lF-DmAGBx8eYxqmQ8jqaYi2iyssF_Nf8dEhaTSQ
CitedBy_id crossref_primary_10_1007_s12325_023_02743_3
crossref_primary_10_1007_s40274_020_6744_2
Cites_doi 10.1016/j.rmed.2016.10.008
10.1590/1414-462x201700010209
10.1590/S0034-89102012005000008
10.1542/peds.2015-4496
10.1007/s40273-018-0726-2
10.1111/pai.12372
10.1111/j.1398-9995.2008.01672.x
10.3109/02770903.2014.999283
10.1186/s40733-016-0029-3
10.1590/s1806-37562016000000352
10.3109/02770903.2016.1171338
10.1542/peds.2007-3273
10.3389/fped.2018.00186
10.1542/peds.2008-2867
10.1186/1471-2466-9-24
10.1590/S0100-879X2006005000129
10.1007/s11096-013-9807-7
ContentType Journal Article
Copyright 2020 Elsevier Ltd
Copyright © 2020 Elsevier Ltd. All rights reserved.
2020. Elsevier Ltd
Copyright_xml – notice: 2020 Elsevier Ltd
– notice: Copyright © 2020 Elsevier Ltd. All rights reserved.
– notice: 2020. Elsevier Ltd
DBID 6I.
AAFTH
NPM
AAYXX
CITATION
7U9
ASE
FPQ
H94
K6X
K9.
M7N
NAPCQ
7X8
DOI 10.1016/j.rmed.2020.105915
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
PubMed
CrossRef
Virology and AIDS Abstracts
British Nursing Index
British Nursing Index (BNI) (1985 to Present)
AIDS and Cancer Research Abstracts
British Nursing Index
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
British Nursing Index
Virology and AIDS Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
AIDS and Cancer Research Abstracts
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1532-3064
EndPage 105915
ExternalDocumentID 10_1016_j_rmed_2020_105915
32217290
S095461112030055X
Genre Journal Article
GeographicLocations Brazil
United States--US
GeographicLocations_xml – name: United States--US
– name: Brazil
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29P
3O-
3V.
4.4
457
4G.
53G
5RE
5VS
6I.
7-5
71M
7RV
7X7
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABLVK
ABMAC
ABMZM
ABOCM
ABVKL
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACPRK
ACRLP
ADBBV
ADEZE
ADFRT
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AEXQZ
AFCTW
AFFNX
AFKRA
AFKWA
AFRAH
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AHMBA
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AQUVI
ASPBG
AVWKF
AXJTR
AZFZN
BENPR
BKEYQ
BKOJK
BLXMC
BNPGV
BNQBC
BPHCQ
BVXVI
CAG
COF
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EMOBN
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEJ
HMK
HMO
HVGLF
HZ~
IHE
IXB
J1W
K-O
KOM
L7B
LCYCR
M0T
M29
M2O
M41
MO0
N9A
NCXOZ
O-L
O9-
OAUVE
OI-
OK1
OU.
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
RIG
ROL
RPZ
RSU
SAE
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSZ
SV3
T5K
UHS
UV1
WH7
WOW
WUQ
X7M
Z5R
ZA5
ZGI
ZXP
~G-
0SF
AAXKI
ADVLN
AFJKZ
AKRWK
NPM
AAYXX
ACRPL
ADNMO
CITATION
7U9
ASE
FPQ
H94
K6X
K9.
M7N
NAPCQ
7X8
ID FETCH-LOGICAL-c428t-103f90d9c181259ef103636b7dadd9d44242e8730d7dde851197c11fd97dd6c93
IEDL.DBID IXB
ISSN 0954-6111
IngestDate Tue Dec 03 23:58:13 EST 2024
Thu Oct 10 22:49:36 EDT 2024
Fri Dec 06 02:50:19 EST 2024
Sat Sep 28 08:29:21 EDT 2024
Fri Feb 23 02:39:43 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Costs
Inhaled corticosteroids
Public health care systems
Asthma admissions
Language English
License This article is made available under the Elsevier license.
Copyright © 2020 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c428t-103f90d9c181259ef103636b7dadd9d44242e8730d7dde851197c11fd97dd6c93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S095461112030055X
PMID 32217290
PQID 2425692995
PQPubID 1216389
PageCount 1
ParticipantIDs proquest_miscellaneous_2384210241
proquest_journals_2425692995
crossref_primary_10_1016_j_rmed_2020_105915
pubmed_primary_32217290
elsevier_sciencedirect_doi_10_1016_j_rmed_2020_105915
PublicationCentury 2000
PublicationDate April 2020
2020-Apr
2020-04-00
20200401
PublicationDateYYYYMMDD 2020-04-01
PublicationDate_xml – month: 04
  year: 2020
  text: April 2020
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Respiratory medicine
PublicationTitleAlternate Respir Med
PublicationYear 2020
Publisher Elsevier Ltd
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier Limited
References IBGE/Diretoria de Pesquisas (bib9)
World Health Organization (bib25)
Santos, Oliveira, Faresin, Santoro, Fernandes (bib23) 2007; 40
Martins, Teixeira (bib26) 2017; 25
bib10
Ferrante, La Grutta (bib7) 2018; 6
Ferreira (bib11) 2015
Cruz, Fernandes, Pizzichini, Fiterman, Pereira, Pizzichini (bib17) 2012; 38
Stirbulov, Lopes da Silva, Maia, Carvalho-Netto, Angelini (bib24) 2016; 53
Sawicki (bib1) 2018
Nunes, Pereira, Morais – Almeida (bib6) 2017; 3
Bahadori, Doyle-Waters, Marra (bib20) 2009; 9
Rachelefsky (bib13) 2009; 123
Castro-Rodriguez, Rodrigo (bib15) 2009; 123
Perry, Braileanu, Palmer, Stevens (bib19) 2018; 37
Wehrmeister, Menezes, Cascaes, Martínez-Mesa, Barros (bib2) 2012; 46
Lang, Carlsen, Haaland, Devulapalli, Munthe-Kaas, Mowinckel (bib22) 2008; 63
Mikalsen, Skeiseid, Tveit, Engelsvold, Øymar (bib12) 2015; 26
Santos, Noblat, Cruz (bib4) 2013; 35
Comaru, Pitrez, Friedrich, Silveira, Pinto (bib5) 2016; 121
Domínguez-Ortega, Phillips-Anglés, Barranco, Quirce (bib8) 2015; 52
Cardoso, Roncada, Silva, Pinto, Jones, Stein (bib16) 2017; 43
Kaiser, Huynh, Bacharier, Rosenthal, Bakel, Parkin, Cabana (bib14) 2016; 137
Silva, Caetano (bib21) 2018; vol. 28
Damasceno, Costa-Carvalho, Solé, Wandalsen (bib3) 2012; 35
Alcindo, Franco, Tatiara (bib18) 2008; 34
Mikalsen (10.1016/j.rmed.2020.105915_bib12) 2015; 26
Lang (10.1016/j.rmed.2020.105915_bib22) 2008; 63
Ferrante (10.1016/j.rmed.2020.105915_bib7) 2018; 6
Santos (10.1016/j.rmed.2020.105915_bib4) 2013; 35
Kaiser (10.1016/j.rmed.2020.105915_bib14) 2016; 137
Cruz (10.1016/j.rmed.2020.105915_bib17) 2012; 38
Santos (10.1016/j.rmed.2020.105915_bib23) 2007; 40
Martins (10.1016/j.rmed.2020.105915_bib26) 2017; 25
Perry (10.1016/j.rmed.2020.105915_bib19) 2018; 37
Damasceno (10.1016/j.rmed.2020.105915_bib3) 2012; 35
Silva (10.1016/j.rmed.2020.105915_bib21) 2018; vol. 28
Domínguez-Ortega (10.1016/j.rmed.2020.105915_bib8) 2015; 52
Wehrmeister (10.1016/j.rmed.2020.105915_bib2) 2012; 46
Alcindo (10.1016/j.rmed.2020.105915_bib18) 2008; 34
Sawicki (10.1016/j.rmed.2020.105915_bib1) 2018
Rachelefsky (10.1016/j.rmed.2020.105915_bib13) 2009; 123
Nunes (10.1016/j.rmed.2020.105915_bib6) 2017; 3
Castro-Rodriguez (10.1016/j.rmed.2020.105915_bib15) 2009; 123
Ferreira (10.1016/j.rmed.2020.105915_bib11) 2015
Cardoso (10.1016/j.rmed.2020.105915_bib16) 2017; 43
Bahadori (10.1016/j.rmed.2020.105915_bib20) 2009; 9
Stirbulov (10.1016/j.rmed.2020.105915_bib24) 2016; 53
Comaru (10.1016/j.rmed.2020.105915_bib5) 2016; 121
IBGE/Diretoria de Pesquisas (10.1016/j.rmed.2020.105915_bib9)
World Health Organization (10.1016/j.rmed.2020.105915_bib25)
References_xml – ident: bib10
  article-title: ANS TABNET. Informações em saúde suplementar
– volume: 35
  start-page: 510
  year: 2013
  ident: bib4
  article-title: A policy of free access to asthma medicines in Brazil: an opportunity for pharmacists to optimize asthma treatment
  publication-title: Int. J. Clin. Pharm.
  contributor:
    fullname: Cruz
– volume: 25
  start-page: 24
  year: 2017
  end-page: 30
  ident: bib26
  article-title: Analysis of hospitalization costs for sickle cell disease in the state of Bahia
  publication-title: Cadernos Saúde Coletiva.
  contributor:
    fullname: Teixeira
– ident: bib25
  article-title: WHO factsheet 206: bronchial asthma
  contributor:
    fullname: World Health Organization
– ident: bib9
  article-title: Coordenação de População e Indicadores Sociais. Gerência de Estudos e Análises da Dinâmica Demográfica. [homepage na Internet] Projeção da população do Brasil e Unidades da Federação por sexo e idade para o período 2000-2030
  contributor:
    fullname: IBGE/Diretoria de Pesquisas
– volume: 35
  start-page: 234
  year: 2012
  end-page: 240
  ident: bib3
  article-title: Custos diretos e indiretos da asma: revisão de literatura
  publication-title: Rev. Bras. Alerg. Imunopatol.
  contributor:
    fullname: Wandalsen
– volume: 38
  start-page: S1
  year: 2012
  end-page: S46
  ident: bib17
  article-title: Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o Manejo da Asma – 2012
  publication-title: J. Bras. Pneumol.
  contributor:
    fullname: Pizzichini
– volume: 63
  start-page: 1054
  year: 2008
  end-page: 1060
  ident: bib22
  article-title: Severe asthma in childhood: assessed in 10 year old's in a birth cohort study
  publication-title: Allergy
  contributor:
    fullname: Mowinckel
– volume: vol. 28
  year: 2018
  ident: bib21
  publication-title: Gastos com pagamentos no Programa Aqui Tem Farmácia Popular: evolução entre 2006-2014
  contributor:
    fullname: Caetano
– volume: 3
  start-page: 1
  year: 2017
  ident: bib6
  article-title: Asthma costs and social impact
  publication-title: Review. Asthma Res. Pract.
  contributor:
    fullname: Morais – Almeida
– volume: 46
  start-page: 242
  year: 2012
  end-page: 250
  ident: bib2
  article-title: Tendência temporal de asma em crianças e adolescentes no Brasil no período de 1998 a 2008. [homepage]
  publication-title: Rev. Saude Publica
  contributor:
    fullname: Barros
– volume: 40
  start-page: 943
  year: 2007
  end-page: 948
  ident: bib23
  article-title: Direct costs of asthma in Brazil: a comparison between controlled and uncontrolled asthmatic patients
  publication-title: Braz. J. Med. Biol. Res.
  contributor:
    fullname: Fernandes
– volume: 43
  start-page: 163
  year: 2017
  end-page: 168
  ident: bib16
  article-title: The impact of asthma in Brazil: a longitudinal analysis of data from a Brazilian national database system
  publication-title: J. Bras. Pneumol.
  contributor:
    fullname: Stein
– year: 2018
  ident: bib1
  article-title: Asthma in Children Younger than 12 Years: Initial Evaluation and Diagnosis
  contributor:
    fullname: Sawicki
– volume: 26
  start-page: 750
  year: 2015
  end-page: 755
  ident: bib12
  article-title: Decline in admissions for childhood asthma, a 26-year period population-based study
  publication-title: Pediatr. Allergy Immunol.
  contributor:
    fullname: Øymar
– volume: 123
  start-page: 353
  year: 2009
  end-page: 366
  ident: bib13
  article-title: Inhaled corticosteroids and asthma control in children: assessing impairment and risk
  publication-title: Pediatrics
  contributor:
    fullname: Rachelefsky
– volume: 6
  start-page: 186
  year: 2018
  ident: bib7
  article-title: The burden of pediatric asthma
  publication-title: Front. Pediatr.
  contributor:
    fullname: La Grutta
– volume: 53
  start-page: 1063
  year: 2016
  end-page: 1070
  ident: bib24
  article-title: Cost of severe asthma in Brazil-systematic review
  publication-title: J. Asthma
  contributor:
    fullname: Angelini
– volume: 121
  start-page: 21
  year: 2016
  end-page: 25
  ident: bib5
  article-title: Free asthma medications reduces hospital admissions in Brazil
  publication-title: Respir. Med.
  contributor:
    fullname: Pinto
– volume: 34
  start-page: 103
  year: 2008
  end-page: 106
  ident: bib18
  article-title: Exemplos brasileiros de programas de controle de asma
  publication-title: J. Bras. Pneumol.
  contributor:
    fullname: Tatiara
– volume: 137
  year: 2016
  ident: bib14
  article-title: Preventing exacerbations in preschoolers with recurrent wheeze: a meta-analysis
  publication-title: Pediatrics
  contributor:
    fullname: Cabana
– volume: 9
  start-page: 24
  year: 2009
  ident: bib20
  article-title: Economic burden of asthma: a systematic review
  publication-title: BMC Pulm. Med.
  contributor:
    fullname: Marra
– year: 2015
  ident: bib11
  article-title: Efeitos do co-pagamento de medicamentos sobre saúde no Brasil: evidências do programa Aqui tem Farmácia Popular
  contributor:
    fullname: Ferreira
– volume: 123
  year: 2009
  ident: bib15
  article-title: Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis
  publication-title: Pediatrics
  contributor:
    fullname: Rodrigo
– volume: 52
  start-page: 529
  year: 2015
  end-page: 537
  ident: bib8
  article-title: Cost effectiveness of asthma therapy: a comprehensive review
  publication-title: J. Asthma
  contributor:
    fullname: Quirce
– volume: 37
  start-page: 155
  year: 2018
  end-page: 167
  ident: bib19
  article-title: The economic burden of pediatric asthma in the United States: literature review of current evidence
  publication-title: Pharmacoeconomics
  contributor:
    fullname: Stevens
– volume: 121
  start-page: 21
  year: 2016
  ident: 10.1016/j.rmed.2020.105915_bib5
  article-title: Free asthma medications reduces hospital admissions in Brazil
  publication-title: Respir. Med.
  doi: 10.1016/j.rmed.2016.10.008
  contributor:
    fullname: Comaru
– volume: 25
  start-page: 24
  issue: 1
  year: 2017
  ident: 10.1016/j.rmed.2020.105915_bib26
  article-title: Analysis of hospitalization costs for sickle cell disease in the state of Bahia
  publication-title: Cadernos Saúde Coletiva.
  doi: 10.1590/1414-462x201700010209
  contributor:
    fullname: Martins
– year: 2018
  ident: 10.1016/j.rmed.2020.105915_bib1
  contributor:
    fullname: Sawicki
– volume: 34
  start-page: 103
  issue: 2
  year: 2008
  ident: 10.1016/j.rmed.2020.105915_bib18
  article-title: Exemplos brasileiros de programas de controle de asma
  publication-title: J. Bras. Pneumol.
  contributor:
    fullname: Alcindo
– volume: 46
  start-page: 242
  issue: 2
  year: 2012
  ident: 10.1016/j.rmed.2020.105915_bib2
  article-title: Tendência temporal de asma em crianças e adolescentes no Brasil no período de 1998 a 2008. [homepage]
  publication-title: Rev. Saude Publica
  doi: 10.1590/S0034-89102012005000008
  contributor:
    fullname: Wehrmeister
– volume: 137
  issue: 6
  year: 2016
  ident: 10.1016/j.rmed.2020.105915_bib14
  article-title: Preventing exacerbations in preschoolers with recurrent wheeze: a meta-analysis
  publication-title: Pediatrics
  doi: 10.1542/peds.2015-4496
  contributor:
    fullname: Kaiser
– volume: 37
  start-page: 155
  issue: 2
  year: 2018
  ident: 10.1016/j.rmed.2020.105915_bib19
  article-title: The economic burden of pediatric asthma in the United States: literature review of current evidence
  publication-title: Pharmacoeconomics
  doi: 10.1007/s40273-018-0726-2
  contributor:
    fullname: Perry
– volume: 26
  start-page: 750
  year: 2015
  ident: 10.1016/j.rmed.2020.105915_bib12
  article-title: Decline in admissions for childhood asthma, a 26-year period population-based study
  publication-title: Pediatr. Allergy Immunol.
  doi: 10.1111/pai.12372
  contributor:
    fullname: Mikalsen
– volume: 38
  start-page: S1
  issue: 1
  year: 2012
  ident: 10.1016/j.rmed.2020.105915_bib17
  article-title: Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o Manejo da Asma – 2012
  publication-title: J. Bras. Pneumol.
  contributor:
    fullname: Cruz
– volume: 63
  start-page: 1054
  year: 2008
  ident: 10.1016/j.rmed.2020.105915_bib22
  article-title: Severe asthma in childhood: assessed in 10 year old's in a birth cohort study
  publication-title: Allergy
  doi: 10.1111/j.1398-9995.2008.01672.x
  contributor:
    fullname: Lang
– volume: 52
  start-page: 529
  year: 2015
  ident: 10.1016/j.rmed.2020.105915_bib8
  article-title: Cost effectiveness of asthma therapy: a comprehensive review
  publication-title: J. Asthma
  doi: 10.3109/02770903.2014.999283
  contributor:
    fullname: Domínguez-Ortega
– volume: 3
  start-page: 1
  year: 2017
  ident: 10.1016/j.rmed.2020.105915_bib6
  article-title: Asthma costs and social impact
  publication-title: Review. Asthma Res. Pract.
  doi: 10.1186/s40733-016-0029-3
  contributor:
    fullname: Nunes
– volume: 43
  start-page: 163
  issue: 3
  year: 2017
  ident: 10.1016/j.rmed.2020.105915_bib16
  article-title: The impact of asthma in Brazil: a longitudinal analysis of data from a Brazilian national database system
  publication-title: J. Bras. Pneumol.
  doi: 10.1590/s1806-37562016000000352
  contributor:
    fullname: Cardoso
– volume: 53
  start-page: 1063
  issue: 10
  year: 2016
  ident: 10.1016/j.rmed.2020.105915_bib24
  article-title: Cost of severe asthma in Brazil-systematic review
  publication-title: J. Asthma
  doi: 10.3109/02770903.2016.1171338
  contributor:
    fullname: Stirbulov
– volume: 123
  start-page: 353
  year: 2009
  ident: 10.1016/j.rmed.2020.105915_bib13
  article-title: Inhaled corticosteroids and asthma control in children: assessing impairment and risk
  publication-title: Pediatrics
  doi: 10.1542/peds.2007-3273
  contributor:
    fullname: Rachelefsky
– volume: 6
  start-page: 186
  year: 2018
  ident: 10.1016/j.rmed.2020.105915_bib7
  article-title: The burden of pediatric asthma
  publication-title: Front. Pediatr.
  doi: 10.3389/fped.2018.00186
  contributor:
    fullname: Ferrante
– year: 2015
  ident: 10.1016/j.rmed.2020.105915_bib11
  contributor:
    fullname: Ferreira
– volume: 123
  issue: 3
  year: 2009
  ident: 10.1016/j.rmed.2020.105915_bib15
  article-title: Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis
  publication-title: Pediatrics
  doi: 10.1542/peds.2008-2867
  contributor:
    fullname: Castro-Rodriguez
– volume: 9
  start-page: 24
  year: 2009
  ident: 10.1016/j.rmed.2020.105915_bib20
  article-title: Economic burden of asthma: a systematic review
  publication-title: BMC Pulm. Med.
  doi: 10.1186/1471-2466-9-24
  contributor:
    fullname: Bahadori
– ident: 10.1016/j.rmed.2020.105915_bib25
  contributor:
    fullname: World Health Organization
– ident: 10.1016/j.rmed.2020.105915_bib9
  contributor:
    fullname: IBGE/Diretoria de Pesquisas
– volume: vol. 28
  year: 2018
  ident: 10.1016/j.rmed.2020.105915_bib21
  contributor:
    fullname: Silva
– volume: 40
  start-page: 943
  issue: 7
  year: 2007
  ident: 10.1016/j.rmed.2020.105915_bib23
  article-title: Direct costs of asthma in Brazil: a comparison between controlled and uncontrolled asthmatic patients
  publication-title: Braz. J. Med. Biol. Res.
  doi: 10.1590/S0100-879X2006005000129
  contributor:
    fullname: Santos
– volume: 35
  start-page: 234
  issue: 6
  year: 2012
  ident: 10.1016/j.rmed.2020.105915_bib3
  article-title: Custos diretos e indiretos da asma: revisão de literatura
  publication-title: Rev. Bras. Alerg. Imunopatol.
  contributor:
    fullname: Damasceno
– volume: 35
  start-page: 510
  year: 2013
  ident: 10.1016/j.rmed.2020.105915_bib4
  article-title: A policy of free access to asthma medicines in Brazil: an opportunity for pharmacists to optimize asthma treatment
  publication-title: Int. J. Clin. Pharm.
  doi: 10.1007/s11096-013-9807-7
  contributor:
    fullname: Santos
SSID ssj0009440
Score 2.3359392
Snippet Asthma is a common chronic disease in childhood, resulting in high costs for health care systems and society. As of June 2011, the Brazilian Unified Health...
BackgroundAsthma is a common chronic disease in childhood, resulting in high costs for health care systems and society. As of June 2011, the Brazilian Unified...
BACKGROUNDAsthma is a common chronic disease in childhood, resulting in high costs for health care systems and society. As of June 2011, the Brazilian Unified...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 105915
SubjectTerms Access to information
Age groups
Asthma
Asthma admissions
Children
Chronic illnesses
Confidence intervals
Corticosteroids
Cost benefit analysis
Cost control
Cost estimates
Costs
Epidemiology
Health care
Hospitals
Information technology
Inhaled corticosteroids
Morbidity
Mortality
Patient admissions
Pediatrics
Population
Population studies
Public health
Public health care systems
Respiratory diseases
Title Cost-benefit impact of free asthma medication provision for the pediatric population
URI https://dx.doi.org/10.1016/j.rmed.2020.105915
https://www.ncbi.nlm.nih.gov/pubmed/32217290
https://www.proquest.com/docview/2425692995
https://search.proquest.com/docview/2384210241
Volume 164
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLYGSIgL4s1gTEHihsr6SB85sgm0MbYLA-0WdW0ihsQ6bd2V346dtkNIwIFT1SaVIjv-bMd2DHDFyenwPG0pN_YtnrqJJQLtW9oTMQ6FE9sUiQ2GQfeZP4z9cQ06VS0MpVWW2F9gukHr8kurpGZrPp22ntA44AGKqmvTlev-GHHY823a5b1x--viXW6KImmyRbPLwpkix2uBGgd9RNe0uxXUGvdn5fSb8WmU0P0e7JbWI7stFrgPNTU7gO1BGR8_hFEnW-bWBPFLT3NWVECyTDO9UIrFy_z1PWYmmm74wcx5Ah2XMTRdGZqCbF517mDzdWevI3i-vxt1ulbZN8FK0JnIEVk9LexUJKS9faG0Q9HaYBKmCGYi5RzVsopQtNMQwS0ykcTEcXQq8D1IhHcMm7Nspk6BcR1HMVI3TWzFkxC9Kc0jJ065S_0ywqgO1xXB5Ly4HkNWeWNvksgribyyIG8d_Iqm8huTJeL3n_81KgbIUsSWknylAI07gcOX62EUDop4xDOVrXCOF3HyablTh5OCcetlIpKh8Sbss38u6hx26K3I4mnAZr5YqQs0UPJJEzZuPpwmbN22X_qP9Oz1u8Om2ZefRh_kug
link.rule.ids 314,780,784,3506,4502,24116,27569,27924,27925,45585,45663,45679,45874
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLbGkIAL4s1gQJC4obI-0keOaGIasO3CJu0WpW0ihsRabd2V346TtkNIwIFjm1SK7OTz59qOAW6odjo8T1nSFb5FUzexWKB8S3lM4FAY26ZIbDgK-hP6NPWnDejWtTA6rbLC_hLTDVpXbzqVNDv5bNZ5QXJAAzyqrq2vXPenG7BJfWS_uKnvPr7yPBg1VZF6tqWnV5UzZZLXAk0OOomu6XfLdG_cn63Tb-zTWKHeHuxW9JHclyvch4acH8DWsAqQH8K4my0LK0YAU7OClCWQJFNELaQkYlm8vgtiwulGIcT8UND_ywhyV4JckOR16w6Sr1t7HcGk9zDu9q2qcYKVoDdRILR6itkpS7T59plUjg7XBnGYIpqxlFK0yzLCs52GiG6RCSUmjqNShs9BwrxjaM6zuTwFQpWIBIo3TWxJkxDdKUUjR6TU1Q0zwqgFt7XAeF7ej8HrxLE3rsXLtXh5Kd4W-LVM-TctcwTwP79r1wrg1Rlbcu0sBcjuGA5fr4fxdOiQh5jLbIVzvIhqp5Y6LTgpFbdeJkIZsjdmn_1zUVew3R8PB3zwOHo-hx09Uqb0tKFZLFbyAtlKEV-a3fgJKNjjtw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cost-benefit+impact+of+free+asthma+medication+provision+for+the+pediatric+population&rft.jtitle=Respiratory+medicine&rft.au=Koltermann%2C+Vanessa&rft.au=Friedrich%2C+Frederico+Orlando&rft.au=Fensterseifer%2C+Ana+Carolina&rft.au=Ongaratto%2C+Renata&rft.date=2020-04-01&rft.pub=Elsevier+Ltd&rft.issn=0954-6111&rft.eissn=1532-3064&rft.volume=164&rft_id=info:doi/10.1016%2Fj.rmed.2020.105915&rft.externalDocID=S095461112030055X
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-6111&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-6111&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-6111&client=summon